Dual Mobility Cup Versus Unipolar Cup
ConditionDislocation, Hip
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorNorthern Orthopaedic Division, Denmark
About this trial
The general purpose of this study is to examine whether the dual mobility cup (Novae® Serf) reduces the number of hip dislocations after total hip replacement, both early dislocation (≤1 year) and late dislocation (\>1 year) after primary THR compared with a conventional cup design (Trabecular MetalTM Modular Acetabular System).
Eligibility criteria
Qualifiers
Patients with hip arthritis who are amenable to surgery with THR and age ≥ 65 years referred to the Department of Orthopedic Surgery at either Section Farsø, Frederikshavn Hospital or Aalborg University Hospital. Patients who are willing to participate in the trial and who give their written, informed consent after receiving oral and written information.
Disqualifiers
Patients who do not wish to participate.
Sequelae of Calvé-Legg-Perthes' disease, caput necrosis, epiphysiolysis.
Proximal femoral or acetabular fracture.
Hip dysplasia with subluxation Crowe types III and IV.
Trial design
Treatments tested in this trial
- dual mobility cup
- unipolar cup
Treatment groups
1,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov